The guidance beat across all three headline metrics is a strong positive catalyst. Traders should position for a gap-up at open. The full Q3 report on September 14 is the next key catalyst — watch for whether the company raises full-year guidance and provides an update on German market expansion.
Price Chart
Executive Summary
High Tide issued preliminary Q3 2026 guidance well above analyst consensus, projecting record revenue of C$195-200M (30-34% YoY growth), gross profit of C$51-53.5M (27-33% YoY), and Adjusted EBITDA of C$15.2-16.5M (43-55% YoY). The low end of guidance exceeds the highest analyst estimate on all three metrics. The company also reported a record quarterly distribution of over 10 tonnes of medical cannabis through its German subsidiary Remexian, up 60% YoY, and noted a return to positive same-store sales in Canada in June and July. This is a strong operational beat that signals accelerating earnings power and market share gains in both Canadian retail and German medical cannabis.
Key Facts
- Q3 2026 revenue guidance of C$195-200M, implying 30-34% YoY growth and 9-12% sequential growth
- Q3 2026 gross profit guidance of C$51-53.5M, implying 27-33% YoY growth
- Q3 2026 Adjusted EBITDA guidance of C$15.2-16.5M, implying 43-55% YoY growth
- Low end of guidance exceeds highest analyst estimate across revenue, gross profit, and Adjusted EBITDA
- Remexian shipped over 10 tonnes of medical cannabis in Q3, a record, up 33% sequentially and 60% YoY
- Canadian same-store sales returned to positive YoV growth in June and remained positive in July
- Full Q3 results to be released September 14, 2026 after market close
Financial Impact
Revenue guidance of C$195-200M vs consensus C$183.4M; Adjusted EBITDA guidance of C$15.2-16.5M vs consensus C$14.0M
Risk Factors
- Guidance is preliminary and subject to change upon full Q3 filing on September 14
- Cannabis sector volatility and regulatory uncertainty in both Canada and Germany
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001279569-26-000733 |
| Document: hightide6k.htm | 0001279569-26-000733 |
| Document: 0001279569-26-000733-index-headers.html | 0001279569-26-000733 |
| Document: 0001279569-26-000733-index.html | 0001279569-26-000733 |
| Document: 0001279569-26-000733.txt | 0001279569-26-000733 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 6-K | $2.61 $2.57 | ▼ −1.53% | ▲ +0.44% | $2.59 (−0.77%) |
Oct 1, 2026 25d ago | 6-K | $2.67 $2.58 | ▼ −3.37% | ▼ −4.67% | $2.59 (−3.00%) |
Sep 28, 2026 28d ago | 6-K | $2.81 $2.73 | ▼ −2.85% | ▼ −4.05% | $2.59 (−7.83%) |
Sep 28, 2026 28d ago | Press Release | $2.81 $2.73 | ▲ +2.85% | ▲ +4.05% | $2.59 (+7.83%) |
Sep 23, 2026 4w ago | 6-K | $2.72 $2.73 | ▲ +0.37% | ▲ +1.04% | $2.59 (−4.78%) |
Sep 14, 2026 6w ago | 6-K | $2.63 $2.63 | · 0.00% | ▼ −0.11% | $2.59 (−1.52%) |
Aug 31, 2026 8w ago | 6-K | $2.51 $2.69 | ▲ +7.17% | ▲ +7.31% | $2.59 (+3.19%) |
Aug 25, 2026 8w ago | 6-K | $2.57 $2.48 | ▼ −3.50% | ▼ −2.96% | $2.59 (+0.78%) |
Aug 25, 2026 8w ago | Press Release | $2.57 $2.48 | ▼ −3.50% | ▼ −2.96% | $2.59 (+0.78%) |
Aug 12, 2026 10w ago | 6-K | $2.33 $2.46 | ▲ +5.58% | ▲ +6.02% | $2.59 (+11.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers